Intravenous alteplase (tPA) is the standard of care for acute ischemic stroke, if it can be given within 3-4.5 hours after stroke onset. Dr. Wilner reviews some important facts about intracranial hemorrhage after the use of intravenous alterpase.
Andrew N. Wilner, MD
Marijuana has been employed since ancient times for the treatment of epilepsy. However, rigorous scientific data supporting its efficacy has been essentially nonexistent until recently.
A new study makes the case for alternatives to opioids in the treatment of migraine.
Causes of concussion include direct trauma, rapid acceleration-deceleration, and blast injury. Dr. Wilner discusses recent literature.
Creutzfeldt-Jacob disease should be considered in the setting of a rapidly progressive dementia with psychiatric symptoms, ataxia, mutism, myoclonus, and pyramidal or extrapyramidal signs.
An expert discusses the latest guidelines to reduce brain injury in adults who are comatose after cardiac resuscitation.
Key details about an option for the treatment of drug-resistant epilepsy in patients who are not surgical candidates.
What do the new AAN guidelines on SUDEP offer? Here’s a quick overview of the key facts.